カテゴリ： 世界, 医療/バイオ, QYResearch

モノアミンオキシダーゼ-Bの世界市場2023年：非選択的MAO-B阻害剤、選択的MAO-B阻害剤

■ 英語タイトル：Global Monoamine Oxidase-B Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8819）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8819
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[モノアミンオキシダーゼ-Bの世界市場2023年：非選択的MAO-B阻害剤、選択的MAO-B阻害剤]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はモノアミンオキシダーゼ-Bのグローバル市場について調査・分析し、世界のモノアミンオキシダーゼ-B市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（非選択的MAO-B阻害剤、選択的MAO-B阻害剤）、用途別セグメント分析（非定型うつ病治療、パーキンソン病治療、その他治療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Novartis、Pfizer、Validus Pharmaceuticals LLC、Eli Lilly & Company、GlaxoSmithKline、Merck & Co、Concordia Pharmsなどが含まれています。モノアミンオキシダーゼ-Bのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、モノアミンオキシダーゼ-B市場規模を算出する際に考慮しました。

・モノアミンオキシダーゼ-B市場の概要
- 製品の定義
- モノアミンオキシダーゼ-Bの種類別セグメント
- 世界のモノアミンオキシダーゼ-B市場規模：タイプ別分析（非選択的MAO-B阻害剤、選択的MAO-B阻害剤）
- モノアミンオキシダーゼ-Bの用途別セグメント
- 世界のモノアミンオキシダーゼ-B市場規模：用途別分析（非定型うつ病治療、パーキンソン病治療、その他治療）
- 世界のモノアミンオキシダーゼ-B市場規模予測（2018年-2029年）
- モノアミンオキシダーゼ-Bの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- モノアミンオキシダーゼ-B市場の競争状況およびトレンド

・モノアミンオキシダーゼ-Bの地域別市場規模
- 北米のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- 米国のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- ヨーロッパのモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- アジア太平洋のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- 中国のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- 日本のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- 韓国のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- インドのモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- オーストラリアのモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- 中南米のモノアミンオキシダーゼ-B市場規模（2018年-2029年）
- 中東・アフリカのモノアミンオキシダーゼ-B市場規模（2018年-2029年）

・種類別セグメント：非選択的MAO-B阻害剤、選択的MAO-B阻害剤
- 世界のモノアミンオキシダーゼ-Bのタイプ別販売量（2018年-2023年）
- 世界のモノアミンオキシダーゼ-Bのタイプ別売上（2018年-2023年）
- 世界のモノアミンオキシダーゼ-Bのタイプ別価格

・用途別セグメント：非定型うつ病治療、パーキンソン病治療、その他治療
- 世界のモノアミンオキシダーゼ-Bの用途別販売量（2018年-2023年）
- 世界のモノアミンオキシダーゼ-Bの用途別売上（2018年-2023年）
- 世界のモノアミンオキシダーゼ-Bの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Novartis、Pfizer、Validus Pharmaceuticals LLC、Eli Lilly & Company、GlaxoSmithKline、Merck & Co、Concordia Pharms

・産業チェーンと販売チャネルの分析
- モノアミンオキシダーゼ-B産業チェーン分析
- モノアミンオキシダーゼ-Bの主要原材料
- モノアミンオキシダーゼ-Bの販売チャネル
- モノアミンオキシダーゼ-Bのディストリビューター
- モノアミンオキシダーゼ-Bの主要顧客

・モノアミンオキシダーゼ-B市場ダイナミクス
- モノアミンオキシダーゼ-Bの業界動向
- モノアミンオキシダーゼ-B市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Monoamine Oxidase-B market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Monoamine Oxidase-B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Monoamine Oxidase-B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Monoamine Oxidase-B include Novartis, Pfizer, Validus Pharmaceuticals LLC, Eli Lilly & Company, GlaxoSmithKline, Merck & Co and Concordia Pharms, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Monoamine Oxidase-B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoamine Oxidase-B.
The Monoamine Oxidase-B market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Monoamine Oxidase-B market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoamine Oxidase-B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Novartis
Pfizer
Validus Pharmaceuticals LLC
Eli Lilly & Company
GlaxoSmithKline
Merck & Co
Concordia Pharms
Segment by Type
Nonselective MAO-B inhibitors
Selective MAO-B inhibitors
Segment by Application
Atypical Depression Treatment
Parkinson’s Disease Treatment
Other Therapy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoamine Oxidase-B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoamine Oxidase-B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Monoamine Oxidase-B Market Overview
1.1 Product Overview and Scope of Monoamine Oxidase-B
1.2 Monoamine Oxidase-B Segment by Type
1.2.1 Global Monoamine Oxidase-B Market Value Comparison by Type (2023-2029)
1.2.2 Nonselective MAO-B inhibitors
1.2.3 Selective MAO-B inhibitors
1.3 Monoamine Oxidase-B Segment by Application
1.3.1 Global Monoamine Oxidase-B Market Value by Application: (2023-2029)
1.3.2 Atypical Depression Treatment
1.3.3 Parkinson’s Disease Treatment
1.3.4 Other Therapy
1.4 Global Monoamine Oxidase-B Market Size Estimates and Forecasts
1.4.1 Global Monoamine Oxidase-B Revenue 2018-2029
1.4.2 Global Monoamine Oxidase-B Sales 2018-2029
1.4.3 Global Monoamine Oxidase-B Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Monoamine Oxidase-B Market Competition by Manufacturers
2.1 Global Monoamine Oxidase-B Sales Market Share by Manufacturers (2018-2023)
2.2 Global Monoamine Oxidase-B Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Monoamine Oxidase-B Average Price by Manufacturers (2018-2023)
2.4 Global Monoamine Oxidase-B Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Monoamine Oxidase-B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monoamine Oxidase-B, Product Type & Application
2.7 Monoamine Oxidase-B Market Competitive Situation and Trends
2.7.1 Monoamine Oxidase-B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monoamine Oxidase-B Players Market Share by Revenue
2.7.3 Global Monoamine Oxidase-B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monoamine Oxidase-B Retrospective Market Scenario by Region
3.1 Global Monoamine Oxidase-B Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Monoamine Oxidase-B Global Monoamine Oxidase-B Sales by Region: 2018-2029
3.2.1 Global Monoamine Oxidase-B Sales by Region: 2018-2023
3.2.2 Global Monoamine Oxidase-B Sales by Region: 2024-2029
3.3 Global Monoamine Oxidase-B Global Monoamine Oxidase-B Revenue by Region: 2018-2029
3.3.1 Global Monoamine Oxidase-B Revenue by Region: 2018-2023
3.3.2 Global Monoamine Oxidase-B Revenue by Region: 2024-2029
3.4 North America Monoamine Oxidase-B Market Facts & Figures by Country
3.4.1 North America Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Monoamine Oxidase-B Sales by Country (2018-2029)
3.4.3 North America Monoamine Oxidase-B Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monoamine Oxidase-B Market Facts & Figures by Country
3.5.1 Europe Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Monoamine Oxidase-B Sales by Country (2018-2029)
3.5.3 Europe Monoamine Oxidase-B Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monoamine Oxidase-B Market Facts & Figures by Country
3.6.1 Asia Pacific Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Monoamine Oxidase-B Sales by Country (2018-2029)
3.6.3 Asia Pacific Monoamine Oxidase-B Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Monoamine Oxidase-B Market Facts & Figures by Country
3.7.1 Latin America Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Monoamine Oxidase-B Sales by Country (2018-2029)
3.7.3 Latin America Monoamine Oxidase-B Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monoamine Oxidase-B Market Facts & Figures by Country
3.8.1 Middle East and Africa Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Monoamine Oxidase-B Sales by Country (2018-2029)
3.8.3 Middle East and Africa Monoamine Oxidase-B Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monoamine Oxidase-B Sales by Type (2018-2029)
4.1.1 Global Monoamine Oxidase-B Sales by Type (2018-2023)
4.1.2 Global Monoamine Oxidase-B Sales by Type (2024-2029)
4.1.3 Global Monoamine Oxidase-B Sales Market Share by Type (2018-2029)
4.2 Global Monoamine Oxidase-B Revenue by Type (2018-2029)
4.2.1 Global Monoamine Oxidase-B Revenue by Type (2018-2023)
4.2.2 Global Monoamine Oxidase-B Revenue by Type (2024-2029)
4.2.3 Global Monoamine Oxidase-B Revenue Market Share by Type (2018-2029)
4.3 Global Monoamine Oxidase-B Price by Type (2018-2029)
5 Segment by Application
5.1 Global Monoamine Oxidase-B Sales by Application (2018-2029)
5.1.1 Global Monoamine Oxidase-B Sales by Application (2018-2023)
5.1.2 Global Monoamine Oxidase-B Sales by Application (2024-2029)
5.1.3 Global Monoamine Oxidase-B Sales Market Share by Application (2018-2029)
5.2 Global Monoamine Oxidase-B Revenue by Application (2018-2029)
5.2.1 Global Monoamine Oxidase-B Revenue by Application (2018-2023)
5.2.2 Global Monoamine Oxidase-B Revenue by Application (2024-2029)
5.2.3 Global Monoamine Oxidase-B Revenue Market Share by Application (2018-2029)
5.3 Global Monoamine Oxidase-B Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Monoamine Oxidase-B Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Monoamine Oxidase-B Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Validus Pharmaceuticals LLC
6.3.1 Validus Pharmaceuticals LLC Corporation Information
6.3.2 Validus Pharmaceuticals LLC Description and Business Overview
6.3.3 Validus Pharmaceuticals LLC Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Validus Pharmaceuticals LLC Monoamine Oxidase-B Product Portfolio
6.3.5 Validus Pharmaceuticals LLC Recent Developments/Updates
6.4 Eli Lilly & Company
6.4.1 Eli Lilly & Company Corporation Information
6.4.2 Eli Lilly & Company Description and Business Overview
6.4.3 Eli Lilly & Company Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly & Company Monoamine Oxidase-B Product Portfolio
6.4.5 Eli Lilly & Company Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Monoamine Oxidase-B Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Merck & Co
6.6.1 Merck & Co Corporation Information
6.6.2 Merck & Co Description and Business Overview
6.6.3 Merck & Co Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck & Co Monoamine Oxidase-B Product Portfolio
6.6.5 Merck & Co Recent Developments/Updates
6.7 Concordia Pharms
6.6.1 Concordia Pharms Corporation Information
6.6.2 Concordia Pharms Description and Business Overview
6.6.3 Concordia Pharms Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Concordia Pharms Monoamine Oxidase-B Product Portfolio
6.7.5 Concordia Pharms Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monoamine Oxidase-B Industry Chain Analysis
7.2 Monoamine Oxidase-B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monoamine Oxidase-B Production Mode & Process
7.4 Monoamine Oxidase-B Sales and Marketing
7.4.1 Monoamine Oxidase-B Sales Channels
7.4.2 Monoamine Oxidase-B Distributors
7.5 Monoamine Oxidase-B Customers
8 Monoamine Oxidase-B Market Dynamics
8.1 Monoamine Oxidase-B Industry Trends
8.2 Monoamine Oxidase-B Market Drivers
8.3 Monoamine Oxidase-B Market Challenges
8.4 Monoamine Oxidase-B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Monoamine Oxidase-B Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Monoamine Oxidase-B Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Monoamine Oxidase-B Market Competitive Situation by Manufacturers in 2022
Table 4. Global Monoamine Oxidase-B Sales (Tons) of Key Manufacturers (2018-2023)
Table 5. Global Monoamine Oxidase-B Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Monoamine Oxidase-B Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Monoamine Oxidase-B Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Monoamine Oxidase-B Average Price (US$/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Monoamine Oxidase-B, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Monoamine Oxidase-B, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Monoamine Oxidase-B, Product Type & Application
Table 12. Global Key Manufacturers of Monoamine Oxidase-B, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoamine Oxidase-B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoamine Oxidase-B as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monoamine Oxidase-B Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Monoamine Oxidase-B Sales by Region (2018-2023) & (Tons)
Table 18. Global Monoamine Oxidase-B Sales Market Share by Region (2018-2023)
Table 19. Global Monoamine Oxidase-B Sales by Region (2024-2029) & (Tons)
Table 20. Global Monoamine Oxidase-B Sales Market Share by Region (2024-2029)
Table 21. Global Monoamine Oxidase-B Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Monoamine Oxidase-B Revenue Market Share by Region (2018-2023)
Table 23. Global Monoamine Oxidase-B Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Monoamine Oxidase-B Revenue Market Share by Region (2024-2029)
Table 25. North America Monoamine Oxidase-B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Monoamine Oxidase-B Sales by Country (2018-2023) & (Tons)
Table 27. North America Monoamine Oxidase-B Sales by Country (2024-2029) & (Tons)
Table 28. North America Monoamine Oxidase-B Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Monoamine Oxidase-B Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Monoamine Oxidase-B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Monoamine Oxidase-B Sales by Country (2018-2023) & (Tons)
Table 32. Europe Monoamine Oxidase-B Sales by Country (2024-2029) & (Tons)
Table 33. Europe Monoamine Oxidase-B Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Monoamine Oxidase-B Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Monoamine Oxidase-B Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Monoamine Oxidase-B Sales by Region (2018-2023) & (Tons)
Table 37. Asia Pacific Monoamine Oxidase-B Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Monoamine Oxidase-B Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Monoamine Oxidase-B Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Monoamine Oxidase-B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Monoamine Oxidase-B Sales by Country (2018-2023) & (Tons)
Table 42. Latin America Monoamine Oxidase-B Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Monoamine Oxidase-B Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Monoamine Oxidase-B Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Monoamine Oxidase-B Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Monoamine Oxidase-B Sales by Country (2018-2023) & (Tons)
Table 47. Middle East & Africa Monoamine Oxidase-B Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Monoamine Oxidase-B Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Monoamine Oxidase-B Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Monoamine Oxidase-B Sales (Tons) by Type (2018-2023)
Table 51. Global Monoamine Oxidase-B Sales (Tons) by Type (2024-2029)
Table 52. Global Monoamine Oxidase-B Sales Market Share by Type (2018-2023)
Table 53. Global Monoamine Oxidase-B Sales Market Share by Type (2024-2029)
Table 54. Global Monoamine Oxidase-B Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Monoamine Oxidase-B Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Monoamine Oxidase-B Revenue Market Share by Type (2018-2023)
Table 57. Global Monoamine Oxidase-B Revenue Market Share by Type (2024-2029)
Table 58. Global Monoamine Oxidase-B Price (US$/Ton) by Type (2018-2023)
Table 59. Global Monoamine Oxidase-B Price (US$/Ton) by Type (2024-2029)
Table 60. Global Monoamine Oxidase-B Sales (Tons) by Application (2018-2023)
Table 61. Global Monoamine Oxidase-B Sales (Tons) by Application (2024-2029)
Table 62. Global Monoamine Oxidase-B Sales Market Share by Application (2018-2023)
Table 63. Global Monoamine Oxidase-B Sales Market Share by Application (2024-2029)
Table 64. Global Monoamine Oxidase-B Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Monoamine Oxidase-B Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Monoamine Oxidase-B Revenue Market Share by Application (2018-2023)
Table 67. Global Monoamine Oxidase-B Revenue Market Share by Application (2024-2029)
Table 68. Global Monoamine Oxidase-B Price (US$/Ton) by Application (2018-2023)
Table 69. Global Monoamine Oxidase-B Price (US$/Ton) by Application (2024-2029)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 73. Novartis Monoamine Oxidase-B Product
Table 74. Novartis Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 78. Pfizer Monoamine Oxidase-B Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Validus Pharmaceuticals LLC Corporation Information
Table 81. Validus Pharmaceuticals LLC Description and Business Overview
Table 82. Validus Pharmaceuticals LLC Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. Validus Pharmaceuticals LLC Monoamine Oxidase-B Product
Table 84. Validus Pharmaceuticals LLC Recent Developments/Updates
Table 85. Eli Lilly & Company Corporation Information
Table 86. Eli Lilly & Company Description and Business Overview
Table 87. Eli Lilly & Company Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Eli Lilly & Company Monoamine Oxidase-B Product
Table 89. Eli Lilly & Company Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Monoamine Oxidase-B Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Merck & Co Corporation Information
Table 96. Merck & Co Description and Business Overview
Table 97. Merck & Co Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. Merck & Co Monoamine Oxidase-B Product
Table 99. Merck & Co Recent Developments/Updates
Table 100. Concordia Pharms Corporation Information
Table 101. Concordia Pharms Description and Business Overview
Table 102. Concordia Pharms Monoamine Oxidase-B Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Concordia Pharms Monoamine Oxidase-B Product
Table 104. Concordia Pharms Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Monoamine Oxidase-B Distributors List
Table 108. Monoamine Oxidase-B Customers List
Table 109. Monoamine Oxidase-B Market Trends
Table 110. Monoamine Oxidase-B Market Drivers
Table 111. Monoamine Oxidase-B Market Challenges
Table 112. Monoamine Oxidase-B Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Monoamine Oxidase-B
Figure 2. Global Monoamine Oxidase-B Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Monoamine Oxidase-B Market Share by Type in 2022 & 2029
Figure 4. Nonselective MAO-B inhibitors Product Picture
Figure 5. Selective MAO-B inhibitors Product Picture
Figure 6. Global Monoamine Oxidase-B Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Monoamine Oxidase-B Market Share by Application in 2022 & 2029
Figure 8. Atypical Depression Treatment
Figure 9. Parkinson's Disease Treatment
Figure 10. Other Therapy
Figure 11. Global Monoamine Oxidase-B Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Monoamine Oxidase-B Market Size (2018-2029) & (US$ Million)
Figure 13. Global Monoamine Oxidase-B Sales (2018-2029) & (Tons)
Figure 14. Global Monoamine Oxidase-B Average Price (US$/Ton) & (2018-2029)
Figure 15. Monoamine Oxidase-B Report Years Considered
Figure 16. Monoamine Oxidase-B Sales Share by Manufacturers in 2022
Figure 17. Global Monoamine Oxidase-B Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Monoamine Oxidase-B Players: Market Share by Revenue in 2022
Figure 19. Monoamine Oxidase-B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Monoamine Oxidase-B Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Monoamine Oxidase-B Sales Market Share by Country (2018-2029)
Figure 22. North America Monoamine Oxidase-B Revenue Market Share by Country (2018-2029)
Figure 23. United States Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Monoamine Oxidase-B Sales Market Share by Country (2018-2029)
Figure 26. Europe Monoamine Oxidase-B Revenue Market Share by Country (2018-2029)
Figure 27. Germany Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Monoamine Oxidase-B Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Monoamine Oxidase-B Revenue Market Share by Region (2018-2029)
Figure 34. China Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Monoamine Oxidase-B Sales Market Share by Country (2018-2029)
Figure 44. Latin America Monoamine Oxidase-B Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Monoamine Oxidase-B Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Monoamine Oxidase-B Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Monoamine Oxidase-B Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Monoamine Oxidase-B by Type (2018-2029)
Figure 54. Global Revenue Market Share of Monoamine Oxidase-B by Type (2018-2029)
Figure 55. Global Monoamine Oxidase-B Price (US$/Ton) by Type (2018-2029)
Figure 56. Global Sales Market Share of Monoamine Oxidase-B by Application (2018-2029)
Figure 57. Global Revenue Market Share of Monoamine Oxidase-B by Application (2018-2029)
Figure 58. Global Monoamine Oxidase-B Price (US$/Ton) by Application (2018-2029)
Figure 59. Monoamine Oxidase-B Value Chain
Figure 60. Monoamine Oxidase-B Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のモノアミン酸化酵素B（MAO-B）市場2022年：市場規模予測（～2028年）
  • 世界のヒトアルデヒドオキシダーゼ市場2022年：市場規模予測（～2028年）
  • 動物用血糖測定システムのグローバル市場展望 2023年-2029年：グルコースオキシダーゼ法、グルコースデヒドロゲナーゼ法、その他
  • 血糖値試験紙用包装の世界市場2023年：試験紙バイアル/チューブ、シングルホイルパウチ
  • フィサラミンの世界市場2023年：95%以上、98%以上
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8819 )"モノアミンオキシダーゼ-Bの世界市場2023年：非選択的MAO-B阻害剤、選択的MAO-B阻害剤" (英文：Global Monoamine Oxidase-B Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。